Burden of GI Cancer and Its Control Strategies in Korea

  • Kwang-Sig Lee (Department of Preventive Medicine and Institute of Health Services Research, Yonsei University) ;
  • Eun-Cheol Park (Department of Preventive Medicine and Institute of Health Services Research, Yonsei University)
  • Received : 2013.09.04
  • Accepted : 2013.10.24
  • Published : 2013.11.30

Abstract

Gastrointestinal (GI) cancers are top priorities for cancer control in Korea. In terms of epidemiological, population-health and economic burden, GI cancers such as stomach, liver and colorectal cancers have been top four cancers in the nation during the past decade and this trend is likely to continue in the near future. In order to reduce the great burden of GI cancer in Korea, the nation might need the following strategies: (1) to put more focus on primary prevention on infection/diet and related research; (2) to improve screening rates for colorectal and stomach cancers, and conduct more cost-effectiveness analysis of these screening programs, e.g., Fecal Occult Blood Test vs. colonoscopy; (3) to establish a more consistent and integrative cost-effectiveness analysis system for new cancer treatments and anticancer drugs; and (4) to place more emphasis on hospice and other palliative care of GI cancer, as well as on the etiology, staging and treatment of pancreas cancer with its poor survival rate.

Keywords

References

  1. World Bank. World development indicators. Retrieved on April 26, 2013 from http://databank.worldbank.org/ddp/home.do.
  2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Qin 2008;58:71-96.
  3. Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 2013;45:1-14.
  4. Cooper BS and Rice DP. The economic cost of illness revisited. Soc Secur Bull 1976;39:21-36.
  5. National Heart, Lung and Blood Institute. NHLBI FY 2007 fact book. Bethesda, MD: National Heart, Lung and Blood Institute 2008.
  6. Park EC. Cancer burden and its reduction strategies in Korea. Seoul: Korea Foundation for Cancer Research 2013.
  7. International Agency for Research on Cancer. GLOBOCAN 2008: estimated cancer incidence, mortality, prevalence and disability-adjusted life years worldwide in 2008. Retrieved on September 26, 2013 from http://globocan.iarc.fr/.
  8. Statistics Korea. Korean statistical information service. Retrieved during January 31-February 15, 2012 from http://kosis.kr/abroad/abroad_01List.jsp.
  9. OECD. OECD economic surveys: Korea 2012. Paris: OECD Publishing, 2012. Figure 1.3. Retrieved on June 20, 2013 from http://dx.doi.org/10.1787/eco_surveys-kor-2012-en.
  10. Park JH, Lee KS, Choi KS. Burden of cancer in Korea during 2000-2020. Cancer Epidemiol 2013:37;353-359.
  11. Stjernward J, Stanley K, Henderson IC. Cancer control: introduction to a series of reports on strategies and approaches. Bull World Health Organ 1986;64:69-71.
  12. Ngoma T. World Health Organization cancer priorities in developing countries. Ann Oncol 2006;17(suppl 8):viii9-viii14.
  13. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinogenesis 2010;31:100-10.
  14. Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol 2012;13:790-801.
  15. Shin DW, Yun YH, Choi IJ, Koh E, Park SM. Cost-effectiveness of eradication of Helicobacter pylori in gastric cancer survivals after endoscopic resection of early gastric cancer. Helicobacter 2009;14:536-544.
  16. Korea National Cancer Center. Cancer facts and figures of Korea. Retrieved on September 12, 2013 from http://ncc.re.kr/english/infor/cff.jsp.
  17. United States Center for Disease Control and Prevention. Vital signs: colorectal cancer screening, incidence, and mortality - United States, 2002-2010. Morbidity and Mortality Weekly Report 2011;60:884-889. Retrieved on October 1, 2013 from http://www.cdc.gov/mmwr/preview/rnmwrhtml/mm6026a4.htm.
  18. Park SM, Yun YH, Kwon SM. Feasible economic strategies to improve screening compliance for colorectal cancer in Korea. World J Gastroenterol 2005;11:1587-1593.
  19. Cho E, Kang MH, Choi KS, Suh MN, Jun JK, Park EG Cost-effectiveness outcomes of the National Gastric Cancer Screening Program in South Korea. Asian Pacific J Cancer Prev 2013;14:2533-2540.
  20. Choi YJ, Cho SJ. Recommendations for Korea's evaluation of medical technology. HIRA Report F8E-2012-20. Table 9. Retrieved on May 27, 2013 from http://www.hira.or.kr/rci_icenter.inter.do?action=listStudyInfo&fldcd=Al&pgmid=HIRAA030095010000.
  21. Park EG National cancer control: theory and reality. Goyang: Korea National Cancer Center, 2010.